1-[4-benzoyl-1-(4-nitrophenyl)-1H-pyrazol-3-yl]-ethanone

ID: ALA1087046

PubChem CID: 45277581

Max Phase: Preclinical

Molecular Formula: C18H13N3O4

Molecular Weight: 335.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)c1nn(-c2ccc([N+](=O)[O-])cc2)cc1C(=O)c1ccccc1

Standard InChI:  InChI=1S/C18H13N3O4/c1-12(22)17-16(18(23)13-5-3-2-4-6-13)11-20(19-17)14-7-9-15(10-8-14)21(24)25/h2-11H,1H3

Standard InChI Key:  HCFFMAVQEHYRBM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   18.0010  -13.7165    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6832  -13.2423    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.4411  -12.4494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6121  -12.4341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3408  -13.2175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1987  -11.7204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6103  -11.0054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3737  -11.7214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9649  -11.0074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1407  -11.0080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7282  -11.7235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1460  -12.4399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9689  -12.4357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9846  -14.5413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2625  -14.9347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2458  -15.7587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9524  -16.1862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6774  -15.7836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6906  -14.9609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1317  -12.0012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8665  -12.3765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0891  -11.1773    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9391  -17.0158    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6458  -17.4415    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2171  -17.4149    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  4  6  1  0
 12 13  2  0
 13  8  1  0
  1 14  1  0
  6  7  2  0
 14 15  2  0
  1  2  1  0
 15 16  1  0
  6  8  1  0
 16 17  2  0
  3  4  1  0
 17 18  1  0
  8  9  2  0
 18 19  2  0
 19 14  1  0
  4  5  2  0
  3 20  1  0
  9 10  1  0
 20 21  1  0
  5  1  1  0
 20 22  2  0
 10 11  2  0
  2  3  2  0
 11 12  1  0
 23 24  2  0
 23 25  1  0
 17 23  1  0
M  CHG  2  23   1  25  -1
M  END

Alternative Forms

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC-38 (857 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Top2a DNA topoisomerase II alpha (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 335.32Molecular Weight (Monoisotopic): 335.0906AlogP: 3.21#Rotatable Bonds: 5
Polar Surface Area: 95.10Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.40CX LogD: 3.40
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.41Np Likeness Score: -1.49

References

1. Riyadh SM, Farghaly TA, Abdallah MA, Abdalla MM, Abd El-Aziz MR..  (2010)  New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity.,  45  (3): [PMID:20022411] [10.1016/j.ejmech.2009.11.050]

Source